Showing results (261-270 of 322) with videos related to

Sort By:
Pageof 33
Leukemia Research|July 19, 2011
Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemiaLuigi Gugliotta, Alessia Tieghi, Giovanni Tortorella, et al.
The Lancet. Haematology|January 27, 2020
Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 studyJean-Jacques Kiladjian, Pierre Zachee, Masayuki Hino, et al.
Blood Advances|June 6, 2020
Enhanced engraftment of human myelofibrosis stem and progenitor cells in MISTRG miceVeronika Lysenko, Nicole Wildner-Verhey van Wijk, Kathrin Zimmermann, et al.
Cancer Medicine|January 28, 2023
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA ProjectGiacomo Coltro, Emanuela Sant'Antonio, Giuseppe A Palumbo, et al.
Blood|March 23, 2010
The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasmsAmy V Jones, Peter J Campbell, Philip A Beer, et al.
International Journal of Cancer|November 9, 2015
Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in primary myelofibrosisSimona Salati, Roberta Zini, Simona Nuzzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2011
Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international studyTiziano Barbui, Juergen Thiele, Francesco Passamonti, et al.
Blood|August 7, 2014
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesisRuggiero Norfo, Roberta Zini, Valentina Pennucci, et al.
American Journal of Hematology|January 28, 2025
TP53 Mutations in Myeloproliferative Neoplasms: Context-Dependent Evaluation of Prognostic RelevanceAyalew Tefferi, Maymona Abdelmagid, Giuseppe G Loscocco, et al.
Cancer|April 13, 2016
The role of sexuality symptoms in myeloproliferative neoplasm symptom burden and quality of life: An analysis by the MPN QOL International Study GroupHolly L Geyer, Bjorn Andreasson, Heidi E Kosiorek, et al.
Pageof 33